These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 404113)

  • 21. Selection of carcinogens and related compounds tested for mutagenic activity.
    Poirier LA; Weisburger EK
    J Natl Cancer Inst; 1979 Apr; 62(4):833-40. PubMed ID: 372655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro mutagenicity assays of chemical carcinogens and related compounds with Salmonella typhimurium.
    Simmon VF
    J Natl Cancer Inst; 1979 Apr; 62(4):893-9. PubMed ID: 372657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
    Walker VE; Meng Q
    Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Methods of identifying carcinogenic factors in medication, food and cosmetics].
    Griciute L
    Acta Zool Pathol Antverp; 1979 Jun; (72):19-34. PubMed ID: 495385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxicological profile of praziquantel, a new drug against cestode and schistosome infections, as compared to some other schistosomicides.
    Frohberg H; Schulze Schencking M
    Arzneimittelforschung; 1981; 31(3a):555-65. PubMed ID: 7195246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening of potential chemical carcinogens by means of mammalian cells in vitro.
    Thust R
    Arch Geschwulstforsch; 1976; 46(7):538-48. PubMed ID: 827273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic toxicity assessment: employing the best science for human safety evaluation part III: the comet assay as an alternative to in vitro clastogenicity tests for early drug candidate selection.
    Witte I; Plappert U; de Wall H; Hartmann A
    Toxicol Sci; 2007 May; 97(1):21-6. PubMed ID: 17204584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of toxicological studies on praziquantel.
    Frohberg H
    Arzneimittelforschung; 1984; 34(9B):1137-44. PubMed ID: 6542381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of in vitro test systems using DNA damage and repair for screening of chemical carcinogens.
    Williams GM
    J Assoc Off Anal Chem; 1979 Jul; 62(4):857-63. PubMed ID: 387709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased production of mutagenic metabolites of carcinogens by tissues from senescent rodents.
    Baird MB; Birnbaum LS
    Cancer Res; 1979 Nov; 39(11):4752-5. PubMed ID: 498103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NTP Technical Report on the metabolism, toxicity and predicted carcinogenicity of diazoaminobenzene (CAS No. 136-35-6).
    Ress NB;
    Toxic Rep Ser; 2002 Sep; (73):1-23, A1-C6. PubMed ID: 12370695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiological and experimental applications to occupational cancer prevention.
    Vainio H; Hemminki K
    J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mouse spot test. Evaluation of its performance in identifying chemical mutagens and carcinogens.
    Styles JA; Penman MG
    Mutat Res; 1985 Nov; 154(3):183-204. PubMed ID: 3900714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacterial systems for carcinogenicity testing.
    Mohn GR
    Mutat Res; 1981 Sep; 87(2):191-210. PubMed ID: 6799816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An evaluation of the mouse sperm morphology test and other sperm tests in nonhuman mammals. A report of the U.S. Environmental Protection Agency Gene-Tox Program.
    Wyrobek AJ; Gordon LA; Burkhart JG; Francis MW; Kapp RW; Letz G; Malling HV; Topham JC; Whorton MD
    Mutat Res; 1983 May; 115(1):1-72. PubMed ID: 6835246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacterial-mammalian mutagenesis correlations: mechanistic significance for carcinogenesis.
    Bartsch H
    Ann N Y Acad Sci; 1983; 407():351-61. PubMed ID: 6576679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro metabolic activation of chemical mutagens. I. Development of an in vitro mutagenicity assay using liver microsomal enzymes for the activation of dimethylnitrosamine to a mutagen.
    Gletten F; Weekes U; Brusick D
    Mutat Res; 1975 Apr; 28(1):113-22. PubMed ID: 806800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The search for relevant short term bioassays for chemical carcinogens: the tribulation of a modern Sisyphus.
    Stich HF; Lam P; Lo LW; Koropatnick DJ; San RH
    Can J Genet Cytol; 1975 Dec; 17(4):471-91. PubMed ID: 812599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.